GOLM1 and hepatocellular carcinoma: More recently, GP73 levels, among other biomarkers, were significantly higher in HCC compared with the other groups (CHC with/without cirrhosis and healthy subjects) in a 2020 Egyptian study of 238 patients (p < 0.001).